Once the most valuable company in the world, Apple (NASDAQ: AAPL ) stock dipped below $400 this week to bottom out at its lowest levels since 2011. Yet as shares of Apple continue to free-fall, the stock's valuation becomes increasingly more attractive. The stock is currently trading at just nine times earnings, well below the market average of 15 times earnings.
From a valuation standpoint, this means Apple stock is trading at its cheapest level in at least 10 years, according to The Wall Street Journal.
Why you want to own it
The stock looks even better when you consider Apple's balance sheet, which boasts zero debt and more than $137 billion in cash and investments. And we can't forget the stock's 2.6% dividend yield. Better still, the company's massive cash reserves mean there's plenty of room for dividend increases or stock buybacks in Apple's future.
Hot Construction Stocks For 2015: Galena Biopharma Inc (GALE)
Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, incorporated on April 3, 2006, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics. The Company is pursuing the development of cancer therapeutics using peptide-based immunotherapy products, including its main product candidate, NeuVaxTM (E75), for the treatment of breast cancer and other tumors. NeuVax is a peptide-based immunotherapy intended to reduce the recurrence of breast cancer in low-to-intermediate HER2-positive breast cancer patients not eligible for trastuzumab (Herceptin; Genentech/Roche). On January 19, 2012, the Company initiated enrollment in its Phase 3 PRESENT clinical trial for NeuVax (E75 peptide plus GM-CSF) vaccine in low-to-intermediate HER2 1+ and 2+ breast cancer patients in the adjuvant setting to prevent recurrence (Clinicaltrials.gov identifier NCT01479244). The Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment study is a randomized, multicenter, multinational clinical trial that will enroll approximately 700 breast cancer patients. The Company�� Phase 2 trial of NeuVax achieved its primary endpoint of disease-free survival (DFS). On April 13, 2011, the Company completed its acquisition of Apthera, Inc.,(Apthera).
The Company focuses to start a Phase 2 trial comparing NeuVax in combination with trastuzumab (Herceptin) versus trastuzumab, alone, in a 300-patient, randomized study in the adjuvant breast cancer setting. The Company's second product candidate, Folate Binding Protein-E39 (FBP), is a vaccine, consisting of the peptides E39 and J65, aimed at preventing the recurrence of ovarian, endometrial, and breast cancers. On February 14, 2012, the Company announced the initiation of a Phase 1/2 clinical trial in two gynecological cancers: ovarian and endometrial adenocarcinomas. Folate binding protein has ! very limited tissue distribution and expression in non-malignant tissue and is over-expressed in more than 90% of ovarian and endometrial cancers, as well as in 20% to 50% of breast, lung, colorectal and renal cell carcinomas.
In April 2011, the Company acquired Apthera Inc and its NeuVax product candidate. The Company focuses on developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide, the advanced of which is NeuVax, which is targeted at preventing the recurrence of breast cancer. NeuVax has had positive Phase 1/2 clinical trial results for the prevention of breast cancer recurrence in patients who have had breast cancer and received the standard of care treatment (surgery, chemotherapy, radiotherapy and hormonal therapy as indicated). The Company had also initiated its Phase 3 PRESENT clinical trial of NeuVax for the prevention of breast cancer recurrence in early-stage low-to-intermediate HER2 breast cancer patients. NeuVax directs killer T-cells to target and destroy cancer cells that express HER2/neu, a protein associated with epithelial tumors in breast, ovarian, pancreatic, colon, bladder and prostate cancers. NeuVax is comprised of a HER2/neu-derived peptide called E75. E75 is a nine-amino acid sequence that is immunogenic (produces an immune response) and GM-CSF is a commercially available protein that acts to stimulate and activate components of the immune system such as macrophages and dendritic cells.
The Company also develops novel applications for NeuVax based on preclinical studies and phases 2 clinical trials which suggest that combining NeuVax and trastuzumab (Herceptin; Genentech/Roche) can increase antigen presentation by tumor cells by promoting receptor internalization and subsequent proteosomal degradation of the HER2 protein. The Company also is pursuing additional therapeutic indications for NeuVax that are in Phase 1/2 clinical trials. RXI-109, is a dermal anti-scarring therapy that targets! connecti! ve tissue growth factor (CTGF) and that may inhibit connective tissue formation in human fibrotic disease.
The Company competes with Roche Laboratories, Inc., Pfizer Inc., Bayer HealthCare AG, Sanofi-Aventis, US, LLC, Amgen, Inc., GlaxoSmithKline plc, Renovo Group plc, CoDa Therapeutics, Inc., Sirnaomics, Inc., FirstString Research, Inc., Merz Pharmaceuticals, LLC, Capstone Therapeutics, Halscion, Inc., Garnet Bio Therapeutics, Inc., AkPharma Inc., Promedior, Inc., Kissei Pharmaceutical Co., Ltd., Eyegene, Derma Sciences, Inc., Healthpoint Biotherapeutics, Pharmaxon, Excaliard Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Marina Biotech, Inc., Tacere Therapeutics, Inc., Benitec Limited, OPKO Health, Inc., Silence Therapeutics plc, Quark Pharmaceuticals, Inc., Rosetta Genomics Ltd., Lorus Therapeutics, Inc., Tekmira Pharmaceuticals Corporation, Arrowhead Research Corporation, Regulus Therapeutics Inc. and Santaris.
Advisors' Opinion:- [By Paul Ausick]
Stocks on the move: Galena Biopharma Inc. (NASDAQ: GALE) is down 15.4% at $1.93 after pricing a secondary offering of 17.5 million units at $2.00. Safeway Inc. (NYSE: SWY) is up 6.1% at $28.21, after an analyst�� upgrade which sent shares to a new 52-week high of $28.88 earlier. Avanir Pharmaceuticals Inc. (NASDAQ: AVNR) is down 18.2% at $4.08.
Top 10 Cheapest Companies To Invest In Right Now: OncoSec Medical Inc (ONCS)
OncoSec Medical Incorporated, incorporated on February 8, 2008, is an emerging drug-medical device company. The Company focused on designing, developing and commercializing medical approaches for the treatment of solid cancers. In March 2011, the Company acquired from Inovio Pharmaceuticals, Inc. (Inovio) certain assets related to the use of drug-medical device combination products for the treatment of different cancers.
The Company�� acquired assets relate to certain non-deoxyribonucleic acid (DNA) vaccine technology and property relating to selective tumor ablation technologies, which it refers to as the OncoSec Medical System (OMS), a therapy which uses an electroporation device to facilitate delivery of chemotherapy agents, or nucleic acids encoding cytokines, into tumors and/or surrounding tissue for the treatment and diagnosis of various cancers. As of January 24, 2012, the Company had not generated any revenue from operations.
Advisors' Opinion:- [By James E. Brumley]
How does the old saying go? Beggars can't be choosers? Two weeks ago, yours truly penned some bullish comments regarding OncoSec Medical Inc. (OTCMKTS:ONCS). The long and short of it was, if ONCS could clear a technical ceiling around $0.36, then life would get much easier for the bulls.
Top 10 Cheapest Companies To Invest In Right Now: Swedbank AB (SWDBY.PK)
Swedbank AB is the parent company of Swedbank. Swedbank consists of subsidiaries, associates and a joint venture. The Company operates in six business areas: Swedish Banking, Baltic Banking, International Banking, Swedbank Markets, Asset Management and Ektornet. On January 20, 2009, Swedbank Robur AB acquired Banco Fonder AB from Alfred Berg. In February 2010, the Company acquired a 15% equity stake in OAO Swedbank from European Bank for Reconstruction and Development (EBRD). During the year ended December 31, 2009, Swedbank sold four branches to Sparbanken Nord, three branches to Sparbanken Dalsland, two branches to Sparbanken Rekarne, one branch to Tidaholms Sparbank and one branch to Sparbanken 1826.
Swedish Banking
Swedish Banking is engaged in offering a range of financial products and services to private customers, corporates, organisations and municipalities through close to 400 branches, as well as the telephone bank and Internet bank in Sweden. Swedbank�� products are also sold through the cooperating savings banks, which account for another 275 branches. The subsidiary in Luxembourg, with a representative office in Spain is included in the business area as well.
Baltic Banking
Baltic Banking offers a range of financial products and services to private and corporate customers in Estonia, Latvia and Lithuania. It offers its services through 226 branches, as well as the telephone bank and Internet bank.
International Banking
International Banking consists of operations outside Swedbank�� home markets, primarily the banking operations in Ukraine and Russia. In addition to Ukraine and Russia, the business area includes the branches in Denmark, Norway, the United States and China, as well as the representative office in Japan. The branch network in Ukraine, consists of 156 branches, serves both private and corporate customers. The Nordic branches offer corporate customers, mainly Swedish customers with operations in! the Nordic markets, a range of financial products and services.
Swedbank Markets
Swedbank Markets has operations in equity, fixed income and currency trading, corporate finance, as well as project, export and acquisition financing. In addition to its operations in Swedbank�� home markets, the business area includes the subsidiaries First Securities ASA in Norway and Swedbank First Securities LLC in New York.
Asset Management
Asset Management, which consists of the subsidiary Swedbank Robur Group, offers services in fund management, institutional and discretionary asset management in all of Swedbank�� home markets. Its customers include private customers, as well as institutions, foundations, municipalities, county councils and other investors. Its products are sold and distributed primarily by Swedish Banking and Baltic Banking and the savings banks in Sweden.
Ektornet
Ektornet is an independent subsidiary of Swedbank AB. It focuses on managing the Company�� repossessed assets and developing them over time. Most of the collateral consists of real estate, the part of which will be in the Baltic countries, though also in the Nordic region and the United States.
Advisors' Opinion:- [By David Hunkar]
Current Dividend Yield: 5.16%
Company: Swedbank AB (SWDBY.PK)
Sector: Oil, Gas & Consumable Fuels
Country: FranceCurrent Dividend Yield: 6.50%
Sector: Banking
Country: Sweden
Top 10 Cheapest Companies To Invest In Right Now: Arch Therapeutics Inc (ARTH)
Arch Therapeutics, Inc. (Arch), formerly Almah, Inc., incorporated on September 16, 2009, operates as a life science company developing polymers containing peptides intended to form gel-like barriers over wounds to stop or control bleeding. Arch is a medical device company offering an approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care. Arch�� products are in preclinical development. The first product, AC5, is designed for hemostasis in minimally invasive (laparoscopic) and open surgical procedures.
AC5
AC5 is a synthetic peptide consisting of naturally occurring amino acids. When squirted or sprayed onto a wound, AC5 intercalates into the nooks and crannies of the connective tissue where it builds itself into a physical, mechanical structure. That structure provides a barrier to leaking substances, including blood and other bodily fluids, regardless of type of surgery or, based on early data, clotting ability.
Advisors' Opinion:- [By John Udovich]
Small cap stocks Derma Sciences Inc (NASDAQ: DSCI), Oculus Innovative Sciences, Inc (NASDAQ: OCLS)�and Arch Therapeutics Inc (OTCBB: ARTH) specialize or have a focus on wound care���a medical problem that has plagued mankind since the dawn of time. After all and think back to our Civil War when disease along with infections resulting from improper wound care probably killed more soldiers than actual battles. Even today, infection after surgery or after receiving a wound or injury of any kind is still a constant threat. And then there is the scaring that can result from any sort of invasive surgery or injury. With those thoughts in mind, here are three small cap wound care stocks trying address these problems:
Top 10 Cheapest Companies To Invest In Right Now: Parker Drilling Company(PKD)
Parker Drilling Company, together with its subsidiaries, provides contract drilling and drilling-related services in the United States, Latin America, Africa and the Middle East (AME), the Asia Pacific, and Commonwealth of Independent States (CIS). As of December 31, 2010, its fleet consisted of 11 rigs in the CIS/AME region; 10 rigs in the Americas region, including 7 land rigs and 1 barge rig in Mexico, and 2 land rigs in Colombia; 5 land rigs in the Asia Pacific region, including 2 rigs in Indonesia, 1 rig in Papua New Guinea, and 2 rigs in New Zealand; 13 barge drilling rigs in the inland shallow waters of the U.S. Gulf of Mexico; and 1 unassigned land rig held in New Iberia, Louisiana. The company also offers premium rental tools, including drill pipe, drill collars, tubing, high- and low-pressure blowout preventers, choke manifolds, junk and cement mills, and casing scrapers for land and offshore oil and gas drilling and workover activities. In addition, it provides non-capital intensive services, such as front end engineering and design; engineering, procurement, construction, and installation; operations and maintenance; and other project management services, which include labor, maintenance, and logistics for operators who own their own drilling rigs. The company serves independent and national oil and gas companies, and integrated service providers. Parker Drilling Company was founded in 1934 and is headquartered in Houston, Texas.
Advisors' Opinion:- [By Rich Smith]
Houston-based Parker Drilling Co. (NYSE: PKD ) has a new CFO.
On Thursday, Parker announced that it has hired away offshore driller Ensco plc's vice president and treasurer, Christopher T. Weber, to become its own senior VP and Chief Financial Officer. Weber will take office on May 20.
Top 10 Cheapest Companies To Invest In Right Now: Performant Financial Corp (PFMT)
Performant Financial Corporation (Performant), incorporated on October 8, 2003, provide technology-enabled recovery and related analytics services in the United States. The Company�� services help identify and recover delinquent or defaulted assets and improper payments for both government and private clients in a broad range of markets. The Company provides its services on an outsourced basis, where the Company handles many or all aspects of its clients��recovery processes. The Company derives its revenues from services for clients in a range of different markets. These markets include student lending and healthcare, as well as its other markets, which include delinquent state taxes and federal Treasury and other receivables. The Company�� clients include 12 of the 32 public sector participants in the student loan industry. In February 2012, it purchased a perpetual software license and computer equipment from HOPS, Inc.
Student Lending
The Company derives its revenues from the recovery of student loans. These revenues are contract-based and consist primarily of contingency fees based on a specified percentage of the amount the Company enables its clients to recover. The Company engages subcontractors to assist in the recovery of a portion of the client�� portfolio. It also receives success fees for the recovery of loans under Master Service Agreements (MSAs) and its revenues under MSA arrangements include fees earned by the activities of its subcontractors. The Company uses its technology to identify, track and communicate with defaulted borrowers on behalf of its clients to implement suitable recovery programs for the repayment of outstanding student loan balances.
The Company�� client�� contract with it to provide recovery services for large pools of student loans generally representing a portion of the total outstanding defaulted balances they manage, which they provide to us as placements on a periodic basis. The Company also restructures and r! ecovers student loans issued directly by banks to students outside of federal lending programs.
Healthcare
The Company derives revenues from the healthcare market primarily from its Recovery Audit Contractor (RAC), contract, under, which it is a prime contractor responsible for detecting improperly paid Part A and Part B Medicare claims in 12 states in the Northeastern United States. Revenues earned under the RAC contract are driven by the identification of improperly paid Medicare claims through both automated and manual review of such claims. The Company outsourced certain aspects of its healthcare recovery process to three different subcontractors.
Other
The Company derives revenues from the recovery of delinquent state taxes, and federal Treasury and other receivables, default aversion services for certain clients, including financial institutions and the licensing of hosted technology solutions to certain clients. For its hosted technology services, the Company licenses its system and integrates its technology into its clients��operations, for which it is paid a licensing fee. The Company�� revenues for these services include contingency fees, fees based on dedicated headcount to its clients and hosted technology licensing fees. The federal agency market consists of government debt subrogated to the Department of the Treasury.
For state and municipal tax authorities, the Company analyzes a portfolio of delinquent tax and other receivables placed with the Company, develop a recovery plan and execute a recovery process designed to maximize the recovery of funds. In some instances, it has also run state tax amnesty programs, which provide one-time relief for delinquent tax obligations, and other debtor management services for its clients. For the Department of the Treasury, it recovers government debt subrogated to it by numerous different federal agencies. The placements it has provided represent a mix of commercial and individual oblig! ations.
Data Management Expertise
The Company�� platform manages and stores large amounts of data throughout the workflow process. This includes both data it has compiled, as well as third-party data.
Data Analytics Capabilities
The Company�� data analytics capabilities screen and allocate massive volumes of recovery inventory. Upon receipt of each placement of student loans, the Company utilize its algorithms to assist its in determining the recovery process and the optimal allocation of recovery specialist resources for each loan. In the healthcare market, the Company analyze millions of Medicare claims to find potential correlations between claims data and improper payments.
Workflow Processes
The Company refers to the patented technology that supports its workflows as Smart Bins. The Company�� workflow processes integrate a range of functions that encompass each stage of a recovery process.
The Company competes with Health Management Systems, Inc., Connolly Consulting, Inc. and CGI Group.
Advisors' Opinion:- [By Magic Diligence]
Much of United Online's appeal was due to its over 4% dividend yield, but the company announced in late January that it would be discontinuing its dividend to focus on growth initiatives. This follows itsNovember spin-off of FTD, which leaves United with 3 cash producing but declining businesses: Classmates.com, NetZero, and Juno. NetZero Mobile Broadband is an interesting product but one with a lot of competition from the carriers. Frankly, the dividend has been the main attraction for some time, and without it this is a declining company with a fair bit of debt. That does not make for the most attractive option. PASS.
Performant Financial (PFMT) - down 28.1%Performant earns fees for collecting delinquent student loans (about 60% of the business) and providing recovery services for improper Medicare payments (close to 30%). The recent sell-off in the stock seems due to comments from Sallie Mae regarding lower rehabilitation fees paid to Guarantee Agencies, which investors expect to "trickle down" to service providers like PFMT. The stock has been sold off dramatically on these assumptions. We should know more when the company reports earnings in the coming weeks, but this is one worth looking at more closely - the firm has been growing revenue at 30%+ rates. WORTHY OF CONSIDERATION.
- [By Roberto Pedone]
Performant Financial (PFMT) provides technology-enabled recovery and related analytics services in the U.S. This stock closed up 6.9% at $11.84 in Friday's trading session.
Friday's Volume: 310,000
Three-Month Average Volume: 261,916
Volume % Change: 60%From a technical perspective, PFMT soared higher here right off both its 200-day moving average of $11.02 and its 50-day moving average at $11.06 with decent upside volume. This move is quickly pushing shares of PFMT within range of triggering a major breakout trade. That trade will hit if PFMT manages to take out some near-term overhead resistance levels at $12.47 to $13.26 with high volume.
Traders should now look for long-biased trades in PFMT as long as it's trending above its 200-day at $11.02 and then once it sustains a move or close above those breakout levels with volume that's near or above 261,916 shares. If that breakout hits soon, then PFMT will set up to re-test or possibly take out its all-time high at $14.09. Any high-volume move above $14.09 will then give PFMT a chance to trend north of $15.
Top 10 Cheapest Companies To Invest In Right Now: Caribbean International Holdings Inc (CIHN)
Caribbean International Holdings Inc., formerly Caribbean Casino and Gaming Corporation, incorporated on February 12, 2009, is focused in the gaming and entertainment company. The Company has a gaming casino, located in the city of Sousa, in the Dominican Republic. In April 2012, it acquired exclusive rights to distribute Bionic Products' Energy Drinks throughout the Caribbean, South and Central America.
The Sosua Bay Grand Casino provides the gaming and entertainment experience to the Domincan Republic. It is equipped with a state of the art lighting and sound system.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Caribbean International Holdings (OTCMKTS: CIHN), Blue Water Global Group Inc (OTCBB: BLUU) and Metrospaces Inc (OTCMKTS: MSPC) have been getting some attention lately in various investment newsletters and all three have focused their activities in the Caribbean or South America. However, all three have been the subject of paid promotions which have helped to get them mentions in various investment newsletters. With that in mind, will bets on the Caribbean or South America pay off big for these three small cap stocks and their investors? Here is a quick reality check:
Caribbean International Holdings (OTCMKTS: CIHN) is All About Wings, Mechanical Bulls and Stem CellsFormerly known as Caribbean Casino & Gaming Corp, small cap Caribbean International Holdings operates as a holding company. On Friday, Caribbean International Holdings rose 8.39% to $0.0369 for a market cap of $315,400 plus CIHN is up 985.3% over the past year and up 7,280% over the past five years according to Google Finance.
No comments:
Post a Comment